Atlanta, GA — Southeast BIO (SEBIO) has elected its new 2008 Board of Directors to lead the organization through its next year of operations. (more…)
ATLANTA, GA — Each year Georgia Bio (GaBio) recognizes individuals, companies or institutions for significant contributions to Georgia’s life sciences industry with its Georgia Bio Community Awards. The 2008 winners are Georgia State Representative Charlice Byrd; Carl V. Patton, Ph.D., Georgia State University President (GSU); Margaret Offermann, M.D., Ph.D., American Cancer Society Deputy National Vice President for Research; and Southeast Bio. The awards were presented at GaBio’s Annual Awards Dinner Thursday evening with more than 400 life sciences professionals in attendance. (more…)
High Point, NC: TransTech Pharma, Inc. and Novo Nordisk A/S announced today that TransTech has acquired all rights from Novo Nordisk to a portfolio of drug candidates being developed to treat metabolic disorders. This portfolio is comprised of three distinct therapeutic approaches to such treatment: H3 receptor antagonists, PPARd agonists, and 11βHSD1 inhibitors. (more…)
Winston-Salem, North Carolina: Targacept, Inc. (Nasdaq: TRGT), a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR Therapeutics (TM), today announced that it has completed the previously announced underwritten public offering of shares of its common stock. The completed offering included 570,000 shares purchased by the underwriters upon exercise of their overallotment option. Targacept issued and sold a total of 4,370,000 shares in the offering, resulting in gross proceeds, before deducting underwriting discounts, commissions and offering expenses, of $30.9 million. (more…)
Research Triangle, NC–NC IDEA has recently awarded $215,000 in grants to five early-stage companies throughout North Carolina in the fall cycle of its bi-annual grant program. (more…)
Gainsville, FL—Medical device maker ViewRay Inc. has closed on a $25 million Series B round led by OrbiMed Advisors and Fidelity Biosciences and joined by Aisling Capital and Kearny Venture Partners. (more…)
Tampa, FL—Accentia Biopharmaceuticals Inc. (NASDAQ:ABPI) announced that it has entered into definitive agreements for a private placement offering of convertible preferred stock and warrants to new and existing institutional investors for gross proceeds of approximately $8.7 million. (more…)
Alachua, FL–NovaMin Technology Inc., developer of a mineral compound used in dental products to strengthen teeth, has raised a $2.2 million C round from Intersouth Partners and U.S. Biomaterials Corp. according to a regulatory filing. (more…)
Research Triangle Park, NC: The North Carolina Biotechnology Center has awarded a $100,000 grant to a consortium coordinated by NCBIO for Phase I planning for a Center of Innovation (COI) in Advanced Medical Technologies. (more…)
